| Literature DB >> 29077603 |
Kuang-Ting Yeh1,2, Ru-Ping Lee3, Ing-Ho Chen1,2, Tzai-Chiu Yu1,2, Kuan-Lin Liu1, Cheng-Huan Peng1, Jen-Hung Wang4, Wen-Tien Wu1,2,3.
Abstract
STUDYEntities:
Mesh:
Year: 2018 PMID: 29077603 PMCID: PMC6159669 DOI: 10.1097/BRS.0000000000002471
Source DB: PubMed Journal: Spine (Phila Pa 1976) ISSN: 0362-2436 Impact factor: 3.468
Demographic Data of the 120 Included Patients
| Male | Female | Total | ||
| N | 32 | 88 | 120 | |
| Age | 64.0 ± 7.9 | 66.4 ± 8.2 | 65.7 ± 8.1 | 0.158 |
| Smoke | – | – | – | <0.001 |
| No | 19 (59.4%) | 83 (94.3%) | 102 (85.0%) | |
| Yes | 13 (40.6%) | 5 (5.7%) | 18 (15.0%) | |
| BMI group | – | – | – | 0.170 |
| Normal | 5 (15.6%) | 29 (33.0%) | 34 (28.3%) | |
| Underweight | 0 (0.0%) | 3 (3.4%) | 3 (2.5%) | |
| Overweight | 13 (40.6%) | 27 (30.7%) | 40 (33.3%) | |
| Obese | 14 (43.8%) | 29 (33.0%) | 43 (35.8%) | |
| TST | – | – | – | <0.001 |
| Normal | 21 (65.6%) | 22 (25.0%) | 43 (35.8%) | |
| Osteopenia | 11 (34.4%) | 42 (47.7%) | 53 (44.2%) | |
| Osteoporosis | 0 (0.0%) | 24 (27.3%) | 24 (20.0%) | |
| S1 involvement | – | – | – | 0.280 |
| No | 14 (43.8%) | 28 (31.8%) | 42 (35.0%) | |
| Yes | 18 (56.3%) | 60 (68.2%) | 78 (65.0%) | |
| Instrumented fusion segments | – | – | – | 0.653 |
| 4 | 21 (65.6%) | 63 (71.6%) | 84 (70.0%) | |
| ≥5 | 11 (34.4%) | 25 (28.4%) | 36 (30.0%) | |
| Proximal fusion level | – | – | – | 0.479 |
| L1 | 17 (53.1%) | 36 (40.9%) | 53 (44.2%) | |
| L2 | 9 (28.1%) | 36 (40.9%) | 45 (37.5%) | |
| T10 | 4 (12.5%) | 6 (6.8%) | 10 (8.3%) | |
| T11 | 0 (0.0%) | 1 (1.1%) | 1 (0.8%) | |
| T12 | 2 (6.3%) | 2 (2.3%) | 4 (3.3%) | |
| T4 | 0 (0.0%) | 1 (1.1%) | 1 (0.8%) | |
| T8 | 0 (0.0%) | 4 (4.5%) | 4 (3.3%) | |
| T9 | 0 (0.0%) | 2 (2.3%) | 2 (1.7%) | |
| Interbody fusion segment | – | – | – | <0.001 |
| ≤2 | 2 (6.3%) | 13 (14.8%) | 15 (12.5%) | |
| 3 | 28 (87.5%) | 44 (50.0%) | 72 (60.0%) | |
| 4 | 2 (6.3%) | 31 (35.23%) | 33 (27.5%) | |
| PI | 48.4 ± 8.2 | 50.1 ± 13.2 | 49.6 ± 12.0 | 0.401 |
| PreOP VAS | 6.1 ± 1.2 | 6.2 ± 1.3 | 6.1 ± 1.3 | 0.681 |
| PreOP ODI | 35.8 ± 3.6 | 37.4 ± 4.2 | 37.0 ± 4.1 | 0.050 |
*P < 0.05 was considered statistically significant after test.
Data are presented as n or mean ± standard deviation. BMI indicates body mass index; ODI, Oswestry disability index; PI, pelvic incidence; TST, total spine T score; VAS, visual analogue scale.
Figure 1Receiving operation curve (ROC) method was used for finding the cutoff value of PI − LL for differentiating between good and worse ODI score. Area under curve (AUC) is 0.747 as acceptable discrimination power of absolute value of PI − LL < 16.2°. LL indicates lumbar lordosis; ODI, Oswestry disability index; PI, pelvic incidence.
Figure 2Receiving operation curve (ROC) method was used for finding the cutoff value of SVA for differentiating between good and worse ODI score. Area under curve (AUC) is 0.702 as acceptable discrimination power of absolute value of SVA less than 38.5 mm. ODI indicates Oswestry disability index; SVA, sagittal vertical axis.
Figure 3Receiving operation curve (ROC) method was used for finding the cutoff value of SVA for differentiating between good and worse ODI score. Area under curve (AUC) is 0.759 as acceptable discrimination power of absolute value of PT is less than 23.4°. ODI indicates Oswestry disability index; PT, pelvic tilt; SVA, sagittal vertical axis.
Risk Factors Associated with Postoperative ODI Score (n = 120)
| Univariate | Multivariate | |||
| Odds Ratio (95% CI) | Odds Ratio (95% CI) | |||
| Age | 1.10 (1.05–1.16) | <0.001 | 1.13 (1.01–1.28) | 0.040 |
| Gender | – | – | – | – |
| Female | References | NA | References | NA |
| Male | 0.60 (0.26–1.39) | 0.235 | 0.45 (0.05–3.68) | 0.454 |
| Smoke | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 1.06 (0.39–2.89) | 0.918 | 2.21 (0.29–17.01) | 0.447 |
| BMI | – | – | – | – |
| Normal | References | NA | References | NA |
| Underweight | 4.18 (0.34–51.24) | 0.263 | 0.89 (0.00–4.39E8) | 0.991 |
| Overweight | 1.55 (0.60–4.01) | 0.371 | 3.04 (0.43–21.70) | 0.268 |
| Obese | 2.19 (0.86–5.58) | 0.100 | 1.12 (0.14–8.89) | 0.918 |
| BMD | – | – | – | – |
| Normal | References | NA | References | NA |
| Osteopenia | 0.79 (0.34–1.81) | 0.573 | 0.31 (0.05–1.92) | 0.206 |
| Osteoporosis | 3.71 (1.27–10.85) | 0.016 | 1.19 (0.13–10.89) | 0.875 |
| PreOP VAS | 1.72 (1.22–2.43) | 0.002 | 1.47 (0.76–2.82) | 0.253 |
| PreOP ODI | 1.30 (1.16–1.46) | <0.001 | 1.23 (1.01–1.54) | 0.047 |
| LL − PI <16.2° | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 0.13 (0.06–0.30) | <0.001 | 1.08 (0.13–8.81) | 0.945 |
| |SVA| <38.5 mm | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 0.28 (0.13–0.60) | 0.001 | 0.35 (0.07–1.64) | 0.182 |
| PT <23.4° | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 0.12 (0.05–0.29) | <0.001 | 0.13 (0.02–0.80) | 0.027 |
| S1 involvement | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 5.50 (2.26–13.40) | <0.001 | 6.00 (1.06–34.11) | 0.043 |
| Instrumented fusion segments | – | – | – | – |
| 4 | References | NA | References | NA |
| ≥5 | 25.6 (8.07–81.20) | <0.001 | 6.86 (0.72–65.46) | 0.094 |
| PI | 1.06 (1.02–1.09) | 0.002 | 0.99 (0.90–1.10) | 0.965 |
| TK | 0.99 (0.96–1.02) | 0.550 | 1.02 (0.96–1.09) | 0.568 |
*P < 0.05 was considered statistically significant after test.
Data are presented as odds ratio (95% CI). BMI indicates body mass index; BMD, bone mineral density; CI, confidence interval; LL, lumbar lordosis; NA, not applicable; ODI, Oswestry disability index; PI, pelvic incidence; PT, pelvic tilt; SVA, sagittal vertical axis; TK, thoracic kyphosis; VAS, visual analogue scale.
Risk Factors Associated With Postoperative Back Pain VAS Score (n = 120)
| Univariate | Multivariate | |||
| Odds Ratio (95% CI) | Odds ratio (95% CI) | |||
| Age | 1.10 (1.05–1.16) | <0.001 | 1.13 (1.03–1.25) | 0.012 |
| Gender | – | – | – | – |
| Female | References | NA | References | NA |
| Male | 0.28 (0.12–0.65) | 0.003 | 0.15 (0.03–0.71) | 0.017 |
| Smoke | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 1.40 (0.49–4.03) | 0.532 | 30.11 (3.82–237.49) | 0.001 |
| BMI group | – | – | – | – |
| Normal | References | NA | References | NA |
| Underweight | 5.82E8 (NA) | 0.999 | 1.01E9 (NA) | 0.999 |
| Overweight | 0.24 (0.09–0.65) | 0.005 | 0.19 (0.04–0.97) | 0.046 |
| Obese | 0.67 (0.25–1.80) | 0.430 | 0.76 (0.15–3.79) | 0.736 |
| TST group | – | – | – | – |
| Normal | References | NA | References | NA |
| Osteopenia | 0.87 (0.33–2.26) | 0.773 | 0.92 (0.20–4.25) | 0.911 |
| Osteoporosis | 2.02 (0.54–7.61) | 0.297 | 0.44 (0.07–3.03) | 0.407 |
| PreOP VAS | 1.42 (1.03–1.96) | 0.033 | 0.95 (0.57–1.59) | 0.854 |
| PreOP ODI | 1.26 (1.11–1.41) | <0.001 | 1.33 (1.09–1.61) | 0.004 |
| LL − PI <16.2° | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 0.28 (0.11–0.70) | 0.006 | 0.27 (0.05–0.82) | 0.044 |
| |SVA| <38.5 mm | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 0.73 (0.31–1.73) | 0.476 | 1.54 (0.41–5.76) | 0.518 |
| PT <23.4° | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 0.43 (0.20–0.90) | 0.026 | 0.55 (0.11–2.80) | 0.473 |
| S1 involvement | – | – | – | – |
| No | References | NA | References | NA |
| Yes | 1.20 (0.56–2.57) | 0.639 | 0.51 (0.12–2.19) | 0.364 |
| Instrumented fusion segments | – | – | – | – |
| 4 | References | NA | References | NA |
| ≥5 | 3.18 (1.30–7.79) | 0.011 | 2.81 (0.12–5.63) | 0.380 |
| PI | 1.01 (0.98–1.04) | 0.527 | 0.93 (0.85–1.02) | 0.114 |
| TK | 1.02 (0.99–1.06) | 0.218 | 1.02 (0.96–1.09) | 0.504 |
*P < 0.05 was considered statistically significant after test.
Data are presented as odds ratio (95% CI). BMI indicates body mass index; BMD, bone mineral density; CI, confidence interval; LL, lumbar lordosis; NA, not applicable; ODI, Oswestry disability index; PI, pelvic incidence; PT, pelvic tilt; SVA, sagittal vertical axis; TK, thoracic kyphosis; TST, total spine T score; VAS, visual analogue scale.